low dose glp 1 agonist GLP-1 receptor agonists Comparing Ozempic, Wegovy and Other
Description
Ahern T, Tobin AM, Corrigan M, et al
As shown in Scheme 22
Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, et al
The analysis did show more claims by GLP-1users for arthritis, sleeping problems, and thyroid and esophageal disorders
A recent Google Trends analysis revealed a significant increase in public interest in these drugs for off-label cosmetic use
